No-Needle glucose monitor: could a wristband replace fingersticks?

NCT ID NCT07425236

Not yet recruiting Knowledge-focused Sponsor: KOS Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a wrist-worn device that uses light sensors and AI to estimate blood sugar without piercing the skin. Up to 100 adults with type 1 diabetes, type 2 diabetes, or prediabetes will wear the device for 15 days while researchers collect data to improve its accuracy. Participants won't see their readings and will continue their usual diabetes care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: KOS Argus Continuous Glucose Monitoring System (noninvasive wrist-worn device)
What this could lead to: If successful, this could lead to a painless, needle-free way to monitor blood glucose for people with diabetes or prediabetes.
What could go wrong: This is an early-stage usability study with no treatment outcomes. The device is still in development and may not be accurate enough for clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus prediabetes syndrome type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES DIABETES MELLITUS, TYPE 1 DIABETES DIABETES MELLITUS, TYPE 2 PREDIABETES

Contacts and locations

Locations

Mills-Peninsula Medical Center - San Mateo Campus

San Mateo, California, 94401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.